Crossmark

Improved adherence with Medicines Use Review service in Slovenia: a randomized controlled trial

Published Online: 2021-03-22

Published Print: 2021-12

Authors

Nabergoj Makovec, Urška https://orcid.org/0000-0001-5194-3314
Locatelli, Igor https://orcid.org/0000-0002-0052-8986
Kos, Mitja https://orcid.org/0000-0002-6801-6450
Funding

Funding for this research was provided by:

Slovene Research Agency (P1-0189)
License Information

Text and Data Mining valid from 2021-03-22

Version of Record valid from 2021-03-22
More Information

Article History

Received: 14 October 2020

Accepted: 28 February 2021

First Online: 22 March 2021

Declarations

:

: The study was approved on 16th June 2016 by the Republic of Slovenia National Medical Ethics Committee (NMEC) (registry number: MZ 0120–321/2016–2, KME 49/06/16). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. After completion of the study, control group patients also received MUR, to comply with proper ethical standards of healthcare. All study patients received MUR free of charge and they did not receive any other compensation. Study pharmacists did not receive any financial or other compensation for their participation.Written informed consent was obtained from all individual participants included in the study upon explanation of the aim and nature of the study.In addition, the trial was retrospectively registered at ClinicalTrials.gov (NCT04417400) on 4th June 2020.

: Patients signed informed consent regarding publishing the aggregated data gathered during the study.

: Authors do not report any competing interest.

Document is current